A 63-year-old woman falls at home and fractures her wrist. She has a 40 pack-year history of smoking. Her doctor recommends a DXA scan, which reveals a very low bone density and prescribes alendronate. How will alendronate help this patient?
Rationale:
Alendronate helps this patient by inhibiting osteoclasts.
Alendronate is a bisphosphonate that binds to bone surfaces and specifically inhibits osteoclast-mediated bone resorption. This reduces bone breakdown, allowing bone formation to predominate, which increases bone density and decreases fracture risk. It is especially useful in osteoporosis, as seen in this patient’s low bone density and fracture history.
A: Enhancing GI calcium absorption does not occur with alendronate; it primarily affects bone cells rather than intestinal calcium transport mechanisms.
B: Inhibiting calcium excretion in the kidneys is unrelated to alendronate, which targets skeletal cells instead of renal calcium handling pathways.
D: Providing the starting material for bone mineralization is the role of calcium and phosphate, not alendronate, which modulates bone resorption processes.
A patient presents with increased growth of skeletal and soft tissue, hypertension, arthritis, menstrual disturbances, and diabetes mellitus. Upon administration of oral glucose, which of the following levels would increase?
Rationale:
Oral glucose administration would increase IGF levels in this patient. IGF (Insulin-like Growth Factor) levels rise in response to growth hormone stimulation and are less suppressed by glucose compared to GH itself. In acromegaly, GH secretion is paradoxically not suppressed by glucose, but IGF remains responsive, reflecting the metabolic activity and tissue effects better than GH.
A: GH Growth hormone typically decreases after oral glucose intake due to negative feedback; thus, GH levels would not increase, contradicting the expected physiological response in glucose tolerance testing.
C: GH and IGF Both hormones do not increase simultaneously after oral glucose; GH usually suppresses, while IGF can increase, making the combined increase inaccurate physiologically.
D: ADH Antidiuretic hormone is unrelated to glucose intake or growth hormone axis; its levels do not typically fluctuate in response to oral glucose administration in this clinical context.
A 37-year-old woman with diabetes is brought to the emergency department unresponsive by her husband. She recently started taking a new medication to control her blood sugar, but her husband could not remember the name of it. Her blood sugar is 45mg\dL. Which of the following diabetes medications is most likely for her condition?
Rationale:
Glipizide is the medication most likely responsible for the patient's hypoglycemia. Glipizide is a sulfonylurea that stimulates insulin release from pancreatic beta cells, which can cause blood sugar levels to drop dangerously low, especially if dosing or food intake is inconsistent. This patient’s low blood sugar and recent medication initiation align with sulfonylurea-induced hypoglycemia.
A: Acarbose Acarbose delays carbohydrate absorption in the gut without increasing insulin secretion, so it rarely causes hypoglycemia. Its mechanism lowers postprandial glucose, making it unlikely to cause severe low blood sugar.
C: Metformin Metformin decreases hepatic glucose production and improves insulin sensitivity but does not stimulate insulin release and rarely causes hypoglycemia, especially as monotherapy, so it is an unlikely cause here.
D: Pramlintide Pramlintide slows gastric emptying and suppresses glucagon but does not directly increase insulin secretion, making hypoglycemia less common; thus, it is not the typical cause of such severe low blood sugar.
Patients receiving iron therapy should be warned about
Rationale:
Patients receiving iron therapy should be warned about blockening of the stool. Iron supplements commonly cause constipation by slowing intestinal motility and hardening stools, necessitating patient awareness to manage this side effect effectively with diet or medication adjustments. Proper counseling helps prevent discomfort and complications from persistent constipation during iron therapy.
A: Dizziness may occur with some medications, but it is not a primary or frequent side effect specifically linked to iron therapy, making it less relevant here.
B: Ringing in the ears is typically associated with ototoxic drugs or high-dose aspirin, not with standard iron supplementation.
C: Danger of sunlight relates to photosensitivity reactions, which iron therapy does not commonly induce, so this warning is not applicable in this context.
Estrogen replacement therapy for postmenopausal women is contraindicated in subjects with
Rationale:
Estrogen replacement therapy for postmenopausal women is contraindicated in subjects with all of the above conditions. Estrogen therapy increases the risk of thromboembolism, can worsen undiagnosed vaginal bleeding by masking serious underlying pathology, and may exacerbate migraine symptoms, making all listed conditions valid contraindications to ensure patient safety and avoid severe adverse effects during treatment.
A: Leg vein thrombosis Estrogen elevates coagulation factors, heightening the risk of deep vein thrombosis, which can lead to life-threatening pulmonary embolism, making this condition a critical contraindication.
B: Undiagnosed vaginal bleeding Unexplained bleeding could indicate malignancy or other serious disorders; estrogen may obscure diagnosis or worsen underlying pathology, necessitating caution before therapy initiation.
C: Migraine Migraines can be aggravated by hormonal fluctuations; estrogen therapy may intensify frequency or severity, potentially deteriorating neurological health and patient quality of life.
A 42-year-old woman presents to clinic with fatigue for the past 2 weeks. She has a history of diabetes, hypothyroidism, lupus, hypertension, and GERD. She currently takes metformin, levothyroxine, prednisone, hydrochlorothiazide, and cimetidine. She reports that her blood sugar has been well controlled. Her TSH and free \T_4 are both within normal limits. She has not had a recent lupus flare. The physician is unsure of the cause of her fatigue and gathers some blood work. The complete blood count is significant for a white blood cell count of 16.1. What medication may be responsible for her elevated white blood cell count?
Rationale:
Prednisone may be responsible for her elevated white blood cell count.
Prednisone, a corticosteroid, commonly causes leukocytosis by demarginating neutrophils and reducing their migration into tissues. This effect increases circulating white blood cells without indicating infection or inflammation. The patient’s normal thyroid and lupus status further support medication-induced leukocytosis, making prednisone the most likely cause given her medication list and lab findings.
A: Cimetidine Cimetidine rarely causes leukocytosis; it more commonly leads to hematologic side effects like thrombocytopenia or agranulocytosis, not elevated white blood cell counts.
B: Hydrochlorothiazide Hydrochlorothiazide does not typically elevate white blood cell counts. It is more associated with electrolyte imbalances and rarely causes hematologic abnormalities.
C: Levothyroxine Levothyroxine regulates thyroid hormone and does not cause leukocytosis. Normal TSH and free T4 levels indicate euthyroid status, making this drug unrelated to elevated white blood cells.
A 33-year-old woman has difficulties with redness of her eyes especially after swimming. She takes oxymetazoline eye drops, which gives her relief. However, this medication can get into the systemic circulation and cause which of the following adverse effects?
Rationale:
Oxymetazoline eye drops can enter systemic circulation and cause headache as an adverse effect. This sympathomimetic drug constricts blood vessels, potentially increasing blood pressure or causing vasoconstriction-related headaches. Its systemic absorption leads to central nervous system effects, including headache, which is a common side effect linked to topical nasal and ocular decongestants like oxymetazoline.
A: Calming This option does not align with oxymetazoline’s pharmacologic profile, which is a vasoconstrictor and stimulant rather than a sedative or calming agent, making calming unrelated to its side effects.
B: Diarrhea Diarrhea is not typically associated with oxymetazoline use, since its mechanism mainly involves alpha-adrenergic receptor stimulation rather than gastrointestinal motility alteration.
C: Fatigue Fatigue is uncommon with oxymetazoline because the drug stimulates adrenergic receptors, generally causing vasoconstriction and alertness rather than sedation or tiredness.
Which one of the following hormones not synthesized in the hypothalamus?
Rationale:
Luteinizing hormone is not synthesized in the hypothalamus. It is produced and secreted by the anterior pituitary gland, whereas the hypothalamus synthesizes releasing hormones that regulate pituitary functions. This distinction is crucial in understanding the endocrine hierarchy and hormone origin in the hypothalamic-pituitary axis, highlighting the specific site of luteinizing hormone production separate from hypothalamic hormones.
A: Corticotropin-releasing hormone is synthesized in the hypothalamus, serving as a key regulator stimulating the anterior pituitary to release adrenocorticotropic hormone, fitting its role in the hypothalamic-pituitary-adrenal axis.
C: Oxytocin, produced in the hypothalamus and secreted by the posterior pituitary, participates in childbirth and lactation, confirming its hypothalamic origin not shared with anterior pituitary hormones.
D: Thyrotropin-releasing hormone originates in the hypothalamus, controlling thyroid-stimulating hormone release from the anterior pituitary, consistent with hypothalamic hormone synthesis for pituitary regulation.
A young married couple complains of being unable to conceive after 9 months of unprotected sex. The wife has normal TSH and FSH levels and a normal pelvic exam. They agree to a trial of letrozole to see if they can increase their fecundity. How does letrozole work?
Rationale:
Letrozole works by inhibiting aromatase.
Inhibiting aromatase decreases estrogen synthesis, which lowers estrogen feedback on the hypothalamus and pituitary. This reduction increases gonadotropin release, particularly FSH, promoting follicular development and ovulation, thereby enhancing fecundity in women with normal thyroid and gonadotropin levels but unexplained infertility.
A: Blocks E₂ receptors on the hypothalamus This option inaccurately attributes letrozole's action to receptor blockade, which it does not perform.
B: Increases sperm production Letrozole's mechanism focuses on female ovulation stimulation, not directly affecting male sperm production.
D: Stimulates follicular development Letrozole indirectly stimulates follicles by hormonal modulation; it does not directly stimulate follicular cells.
A 46-year-old male patient has Cushing's syndrome that is due to the presence of an adrenal tumor. Which of the following drugs would be expected to reduce the signs and symptoms of this man's disease?
Rationale:
Ketoconazole would be expected to reduce the signs and symptoms of this man's disease. Ketoconazole inhibits adrenal steroidogenesis by blocking enzymes such as 17α-hydroxylase and 11β-hydroxylase, leading to decreased cortisol synthesis. This reduction in cortisol levels directly alleviates hypercortisolism symptoms caused by the adrenal tumor in Cushing's syndrome, making it an effective therapeutic choice.
A: Betamethasone is a synthetic glucocorticoid that would worsen hypercortisolism by adding exogenous steroids, thereby increasing cortisol effects rather than reducing them.
B: Cortisol supplementation would exacerbate symptoms by increasing glucocorticoid activity, opposing the goal of decreasing cortisol production in Cushing’s syndrome.
C: Fludrocortisone primarily affects mineralocorticoid receptors and does not reduce cortisol production or symptoms in Cushing’s syndrome caused by adrenal tumors.
Anabolic steroids are contraindicated in
Rationale:
Anabolic steroids are contraindicated in prostatic carcinoma. This is because anabolic steroids can stimulate the growth of hormone-sensitive tissues, including prostate cancer cells, potentially exacerbating the malignancy. Their androgenic effects may promote tumor progression, making their use harmful and unsafe for patients with prostatic carcinoma, thus contraindicating anabolic steroid administration in such cases to prevent worsening the disease.
B: Carcinoma of the breast in females is not the primary contraindication as anabolic steroids’ impact is more significant in androgen-sensitive tissues like the prostate, whereas breast carcinoma involves different hormonal pathways less directly affected by anabolic steroids.
C: Promoting growth in hypogonadal children is a therapeutic indication for anabolic steroids, as they aid in developing secondary sexual characteristics and growth, making this choice a valid use rather than a contraindication.
D: Refractory anaemias associated with hypoplastic bone marrow are treated with anabolic steroids to stimulate erythropoiesis, indicating a beneficial role rather than a contraindication in managing these hematologic conditions.
Drugs producing allergic reactions generally act as
Rationale:
Drugs producing allergic reactions generally act as Haptenes. Haptenes are small molecules that become antigenic only when bound to larger proteins, triggering an immune response. They do not independently elicit antibody production but form complexes recognized by the immune system, leading to hypersensitivity reactions characteristic of drug allergies, distinguishing them from complete antigens or immune system components.
A: Complete antigens consist of larger molecules capable of independently stimulating immune responses, unlike drugs acting as haptenes which require protein binding to provoke allergic reactions.
C: Antibodies are immune proteins that target antigens; they do not initiate allergic responses but participate after hapten-protein complexes form.
D: Mediators are substances released during allergic responses, not the initial substances causing the reaction, which are haptenes bound to proteins.
A 43-year-old man with dyslipidemia comes to the clinic for a routine checkup. He currently takes atorvastatin but is not achieving his target lipid profile. The physician prescribes colesevelam to help. Which of the following changes is expected as a result of this new therapy?
Rationale:
Colesevelam therapy is expected to cause hyperglycemia.
Colesevelam, a bile acid sequestrant, lowers LDL cholesterol but can impair glycemic control by reducing glucose absorption and altering incretin hormones, leading to elevated blood glucose levels. This effect is notable in diabetic patients or those at risk, making hyperglycemia a recognized adverse consequence of colesevelam therapy in clinical practice.
A: Decreased HDL This is inaccurate because colesevelam typically has minimal effect on HDL cholesterol, which usually remains stable or slightly increases rather than decreases with bile acid sequestrant use.
B: Decreased triglycerides Colesevelam often causes a modest increase in triglycerides due to altered lipid metabolism, so a decrease in triglycerides does not align with its pharmacological impact.
D: Increased LDL Colesevelam lowers LDL cholesterol by binding bile acids; hence, an increase in LDL contradicts its primary lipid-lowering mechanism and expected therapeutic outcome.
A 72-year-old woman with myasthenia gravis is brought to the emergency department with decreased responsiveness. She has a history of diabetes, hypertension, Alzheimer's disease, and stroke. Physical examination reveals significant abdominal tenderness with guarding and peritoneal signs. Which of the following is a medication that should be discontinued immediately in this patient?
Rationale:
Neostigmine should be discontinued immediately in this patient. Neostigmine, an acetylcholinesterase inhibitor, can exacerbate cholinergic crisis, especially in patients with myasthenia gravis and acute abdominal pathology. Its continuation may worsen muscle weakness and respiratory compromise. The presence of peritoneal signs necessitates urgent surgical evaluation, and neostigmine could mask or complicate clinical assessment and management.
A: Insulin This patient’s diabetes requires ongoing management; stopping insulin abruptly risks hyperglycemia and diabetic complications, which do not directly worsen the acute abdominal condition or myasthenic crisis.
C: Nifedipine Nifedipine, a calcium channel blocker, primarily affects blood pressure and cardiac function and does not contribute to muscle weakness or interfere with myasthenic crisis management in this context.
D: Rivastigmine Rivastigmine, used for Alzheimer’s, does not exacerbate myasthenic symptoms or acute abdominal emergencies and therefore is not urgent to discontinue despite the patient’s altered mental status.
Regarding the biosynthesis of thyroid hormones, if a novel medication was developed to block the proteolytic release of hormones, this medication would act at which of the following sites?
Rationale:
The medication would act at Location 4.
Location 4 is where proteolytic cleavage of thyroglobulin occurs, releasing thyroid hormones T3 and T4 into the bloodstream. Blocking this site prevents hormone liberation, directly halting their secretion despite earlier biosynthetic steps remaining intact. This step is essential for converting stored hormone precursors into active thyroid hormones available for physiological use.
A: Location 1 involves initial iodide uptake, unrelated to proteolytic hormone release mechanisms.
B: Location 2 is associated with iodination of tyrosine residues, not hormone liberation by proteolysis.
C: Location 3 pertains to coupling reactions forming hormone precursors, preceding proteolytic release.
Factors likely to cause an increase in the blood urea nitrogen (BUN) level include
Rationale:
An increase in blood urea nitrogen (BUN) level is caused by chronic kidney disease. Chronic kidney disease impairs the kidneys' ability to excrete urea, leading to its accumulation in the blood. This condition reduces glomerular filtration rate, causing nitrogenous waste buildup. Elevated BUN reflects diminished renal clearance, making chronic kidney disease a primary factor in raised BUN levels.
A: Intramuscular injection of diazepam (Valium) does not influence BUN levels as it primarily affects the central nervous system without altering renal urea clearance or protein metabolism significantly.
B: Severe liver disease typically lowers BUN because the liver synthesizes urea from ammonia; impaired liver function reduces urea production, decreasing blood urea nitrogen concentration instead of increasing it.
Adaptive neurophysiological changes produced by repeated administration of a drug, which result in the appearance of characteristic withdrawal syndrome on discontinuation of the drug is called
Rationale:
Adaptive neurophysiological changes produced by repeated administration of a drug, resulting in a characteristic withdrawal syndrome upon discontinuation, is called physical dependence.
Physical dependence involves the body's biological adaptation to a drug, causing withdrawal symptoms when the drug is stopped. This distinguishes it from purely psychological reliance or misuse, as it specifically refers to physiological changes and withdrawal manifestations linked to chronic drug exposure.
A: Drug addiction entails compulsive drug use despite harm, involving both physical and psychological elements, but does not solely define withdrawal-related neurophysiological changes.
B: Drug abuse describes harmful or excessive drug use without necessarily involving adaptive neurophysiological modifications or resultant withdrawal symptoms.
C: Psychological dependence centers on emotional or mental reliance on a drug, lacking the physical withdrawal syndrome characteristic of neuroadaptive changes.
A 54-year-old woman presents to the primary care clinic with hot flashes and irregular menstrual cycles. These symptoms started about 3 months ago and have worsened recently. She has always had regular menstrual cycles until 3 months ago. She would like to start hormone replacement therapy but estrogen only. What is a common side effect of unopposed estrogen replacement therapy?
Rationale:
Unopposed estrogen replacement therapy commonly increases the risk of endometrial cancer. This occurs because estrogen stimulates the endometrial lining to proliferate without progesterone’s balancing effect, leading to hyperplasia and potential malignant transformation. Women with an intact uterus require combined hormone therapy to mitigate this risk, making the increased risk of endometrial cancer a well-documented side effect of estrogen alone.
A: Depression Hormonal fluctuations can influence mood, but depression is not a primary or common adverse effect specifically linked to unopposed estrogen therapy.
C: Osteoporosis Estrogen actually helps prevent osteoporosis by maintaining bone density; lack of estrogen, not unopposed therapy, typically contributes to bone loss.
D: Rash Skin reactions are uncommon with estrogen alone and are not recognized as a frequent or characteristic side effect in hormone replacement regimens.
A patient presents with rhabdomyolysis and depletion of 2-3-diphosphoglycerate. A common complication of high levels of the molecule being affected in this patient would be:
Rationale:
Metastatic calcification is a common complication associated with high levels of calcium-phosphate product, which can occur due to rhabdomyolysis-induced tissue damage and altered phosphate metabolism.
Metastatic calcification results from hypercalcemia and phosphate imbalance, leading to calcium salt deposition in normal tissues, often triggered by rhabdomyolysis through released intracellular phosphate and calcium, causing widespread soft tissue calcification.
B: Dystrophic calcification involves calcium deposition in damaged or necrotic tissues without systemic calcium imbalance, which does not align with the systemic phosphate disturbances in rhabdomyolysis.
C: Heart failure is not directly caused by elevated calcium-phosphate levels or 2,3-diphosphoglycerate depletion; it typically arises from primary cardiac dysfunction rather than metabolic derangements here.
D: Respiratory failure is unrelated to calcium-phosphate metabolism disturbances or rhabdomyolysis-induced 2,3-diphosphoglycerate depletion, as it primarily involves pulmonary or neuromuscular pathology.
A 43-year-old woman presents to the primary care clinic for follow-up. During her last visit, her fasting lipid panel showed a triglyceride level of 315mg\dL. She tried to eat healthier and increase her exercise regimen. Her lipid panel was rechecked and showed a total cholesterol of 189mg\dL, LDL of 88mg\dL, HDL of 52mg\dL, and triglycerides of 286mg\dL. What medication will lower the triglyceride level the most?
Rationale:
Gemfibrozil will lower triglyceride levels the most in this patient. It is a fibrate that activates peroxisome proliferator-activated receptor alpha (PPARα), which increases lipoprotein lipase activity, enhancing triglyceride clearance and reducing hepatic triglyceride production, making it the most effective medication for significantly lowering elevated triglycerides compared to other lipid-lowering agents.
A: Colestipol Binds bile acids reducing LDL cholesterol but has minimal impact on triglycerides, making it less effective for treating hypertriglyceridemia.
B: Ezetimibe Inhibits cholesterol absorption in the intestines primarily lowering LDL cholesterol, with negligible effect on triglyceride levels.
D: Niacin Lowers LDL and raises HDL modestly; it reduces triglycerides but not as potently or consistently as fibrates like gemfibrozil.
Which of the following preparations is used to attain remission of thyrotoxicosis?
Rationale:
Propylthiouracil is used to attain remission of thyrotoxicosis. This medication inhibits thyroid hormone synthesis by blocking thyroid peroxidase and peripheral conversion of T4 to T3, effectively reducing excess thyroid hormone levels. It is specifically indicated for controlling hyperthyroidism symptoms and achieving remission, which distinguishes it from symptomatic or hormone replacement treatments.
A: Propranolol Primarily controls symptoms like tachycardia and tremors without altering thyroid hormone production or causing remission, functioning only as a beta-blocker for symptomatic relief in thyrotoxicosis.
B: Liotrix Combines T3 and T4 hormones for replacement therapy, unsuitable for treating hyperthyroidism or inducing remission since it increases hormone levels instead of suppressing them.
C: Levothyroxine Synthetic T4 used for hypothyroidism replacement therapy; it does not reduce thyroid hormone production or treat thyrotoxicosis, thus inappropriate for remission induction.
A 26-year-old woman with infertility and her 23-yearold husband with a history of bilateral undescended testicles desires to start a family. She is currently taking a fertility medication but is troubled by some unusual and troubling side effects. She experiences heat and cold intolerance and mood swings. She complains of visual changes, and this makes her depressed. Which of the following medications is she most likely taking?
Rationale:
Clomiphene citrate is the medication she is most likely taking. Clomiphene citrate is commonly used to induce ovulation in women with infertility and can cause side effects such as mood swings, heat and cold intolerance, and visual disturbances. These symptoms align with her complaints, indicating clomiphene citrate as the most probable drug responsible for her side effects.
B: Danocrine is primarily used for endometriosis and causes androgenic side effects like weight gain and acne, not typically mood swings or visual changes, making it an unlikely cause of her symptoms.
C: Human chorionic gonadotropin mainly stimulates ovulation but rarely causes mood or visual disturbances, so it does not match the patient's unusual side effects.
D: Pulsatile GnRH triggers ovulation without commonly producing heat/cold intolerance or visual changes, thus it does not correspond to the troubling symptoms described.
Transdermal estradiol differs from oral estrogen therapy in that it
Rationale:
Transdermal estradiol differs from oral estrogen therapy in that it does not involve obtaining FSH or LH from any urine source.
D is correct because transdermal estradiol bypasses hepatic first-pass metabolism, providing stable hormone levels without relying on urinary gonadotropins. This method reduces risks associated with oral estrogen, such as thrombosis, and avoids hormone fluctuations linked to oral administration. The other options inaccurately associate estradiol delivery with hormone extraction from urine.
A: FSH + LH obtained from urine of menstruating women incorrectly links transdermal estradiol to urinary hormone extraction, which is unrelated to its administration or pharmacokinetics.
B: LH obtained from urine of pregnant women mistakenly associates transdermal estradiol with urinary LH sources, which do not influence its delivery or effects.
C: FSH + LH obtained from urine of menopausal women wrongly suggests that transdermal estradiol depends on gonadotropins from menopausal urine, which is irrelevant to its pharmacological mechanism.
Under physiological conditions the rate limiting enzyme in the generation of angiotensin II is
Rationale:
Renin is the rate limiting enzyme in the generation of angiotensin II under physiological conditions. Renin initiates the cascade by cleaving angiotensinogen to angiotensin I, controlling the overall pace of angiotensin II production. Its activity regulates the downstream enzymatic steps, making it the primary controlling factor in the renin-angiotensin system and thus the rate limiting enzyme in this process.
B: Angiotensin converting enzyme transforms angiotensin I to angiotensin II but functions downstream and does not control the initial pace of the cascade, so it is not rate limiting.
C: Aminopeptidase modifies angiotensin peptides later in the pathway and does not initiate or limit the production speed of angiotensin II.
D: Angiotensinase degrades angiotensin peptides, reducing activity, but does not regulate the generation rate of angiotensin II itself.
What category class is the drug Senna?
Rationale:
Senna is classified as a laxative. Senna stimulates bowel movements by irritating the colon's lining, thereby promoting defecation. It is widely used to treat constipation due to its natural origin and effectiveness in softening stools. This makes it an ideal choice for managing occasional constipation rather than other unrelated medical conditions.
B: Anti-Ulcer does not apply to Senna because it does not reduce stomach acid or protect the gastrointestinal lining, which are primary characteristics of anti-ulcer medications.
C: ACE inhibitor is unrelated to Senna as ACE inhibitors primarily manage hypertension by affecting the renin-angiotensin system, not bowel motility or stool softening.
D: Benzodiazepines function as central nervous system depressants for anxiety or seizures, differing fundamentally from Senna’s role in stimulating intestinal activity and alleviating constipation.
Thick, viscid, adhesive liquids made by dispersing gum in water
Rationale:
Thick, viscid, adhesive liquids made by dispersing gum in water are called mucilage. Mucilage is a gelatinous substance formed when gum dissolves in water, creating a sticky, cohesive liquid used for binding or coating. Its texture and adhesive properties distinguish it from other liquid preparations, making it the precise term for such viscous gum-based solutions.
A: Effervescent refers to liquids that release gas bubbles and fizz, which contrasts with the thick, sticky nature of gum dispersions described here.
C: Spirits are alcoholic or volatile liquids, lacking the adhesive and viscous quality that characterizes gum-based mucilage preparations.
D: Collyria are medicinal eye washes or solutions, not thick, adhesive liquids formed by dispersing gum in water.
Which of the following is true of anabolic steroids?
Rationale:
Anabolic steroids are androgens with relatively selective anabolic activity. This means they primarily promote muscle growth and protein synthesis while minimizing androgenic effects like masculinization. Their selective activity allows therapeutic use in certain conditions but limits long-term use due to potential side effects. The distinction emphasizes their functional profile compared to other steroids with broader androgenic actions.
A: They are testosterone congeners having anabolic but no androgenic activity inaccurately claims zero androgenic effects, whereas anabolic steroids retain some androgenic properties despite selectivity.
C: They are suitable for long-term therapy in children contradicts clinical guidelines, as prolonged use risks stunted growth and adverse hormonal effects.
D: Both (b) and (c) incorrectly combines a true statement with an invalid one, making this choice factually inconsistent and misleading.
Which one of the following statements about hormone replacement therapy (HRT) regimens in menopause is accurate?
Rationale:
Hormone replacement therapy (HRT) commonly includes a progestin to reduce the risk of endometrial cancer. Progestins counteract estrogen’s proliferative effect on the endometrium, thereby lowering the likelihood of hyperplasia and cancer development. This combination is standard in women with an intact uterus to ensure safety during menopause symptom management, aligning with established clinical guidelines and risk mitigation strategies.
B: It has not been conclusively demonstrated that HRT reduces migraine attacks; evidence is limited and inconsistent, making this statement unsupported by current clinical research and practice guidelines.
C: HRT does not include steroids that induce cytochrome P450 enzymes; its components primarily focus on hormonal replacement rather than enzyme induction, which affects drug metabolism differently.
D: HRT is not universally contraindicated in women with diabetes; its use depends on individual risk assessment, and diabetes alone does not mandate avoidance of hormone therapy.
Recombinant human insulin in diabetes mellitus:
Rationale:
Recombinant human insulin in diabetes mellitus may require a lower effective dose than animal insulin.
B: Recombinant human insulin closely resembles endogenous insulin, enhancing receptor affinity and metabolic efficacy, often resulting in a reduced required dosage compared to animal-derived insulin. This similarity minimizes immunogenicity and improves glucose control, making lower doses both effective and safer for patients.
A: Never produces allergic reactions overlooks that human insulin can still cause hypersensitivity in rare cases, unlike the absolute absence of allergy suggested here.
C: Patients are less aware of hypoglycaemia contradicts evidence; awareness levels depend on individual factors, not insulin type, making this an inaccurate generalization.
D: Should not be given intravenously is misleading since recombinant human insulin can be administered intravenously, especially in emergencies like diabetic ketoacidosis.
Avidin, a protein found in egg white is an antagonist of
Rationale:
Avidin is an antagonist of Biotin. Avidin binds strongly to biotin, preventing its absorption in the digestive tract and leading to biotin deficiency if consumed in large amounts. This binding inhibits biotin's biological functions, such as acting as a coenzyme in carboxylation reactions essential for metabolism, highlighting avidin's antagonistic role specifically against biotin.
B: Pantothenic acid does not interact with avidin; no binding affinity exists, so avidin cannot inhibit or block pantothenic acid’s metabolic functions or absorption in the body.
C: Choline is unrelated to avidin’s binding properties and is unaffected by avidin presence, as avidin specifically targets biotin molecules, not choline.
D: Pyridoxal is a form of vitamin B6 and lacks the structural compatibility for avidin binding, so avidin does not antagonize or interfere with pyridoxal activity.
A 75-year-old man with metastatic prostate cancer is placed on leuprolide administered monthly in an intramuscular injection. This agent will act at which of the following areas on the succeeding diagram?
Rationale:
Leuprolide’s site of action cannot be determined from the diagram alone.
Leuprolide is a GnRH agonist affecting the hypothalamic-pituitary-gonadal axis, initially stimulating then downregulating GnRH receptors in the pituitary, reducing LH and testosterone. Without the diagram’s labels or context, pinpointing the exact anatomical location it acts on is impossible, as it influences multiple levels, including hypothalamus and pituitary, not just a single point.
A: Letter A assumes a specific structure without context, lacking the necessary diagrammatic reference to confirm the drug’s action site on the hormonal axis.
B: Letter B presumes the pituitary or hypothalamus without diagram clarity, making it speculative and unsupported by the given information.
C: Letter C implies a discrete anatomical target, but leuprolide’s mechanism involves multiple endocrine sites, not a single isolated area, which the diagram fails to specify.